These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18391988)

  • 1. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.
    Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR
    Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.
    Lioznov MV; Freiberger P; Kröger N; Zander AR; Fehse B
    Bone Marrow Transplant; 2005 May; 35(9):909-14. PubMed ID: 15765109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
    Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
    Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants.
    De Boer F; Dräger AM; Van der Wall E; Pinedo HM; Schuurhuis GJ
    Bone Marrow Transplant; 1998 Dec; 22(11):1103-10. PubMed ID: 9877274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation.
    Frey NV; Lazarus HM; Goldstein SC
    Bone Marrow Transplant; 2006 Sep; 38(6):399-405. PubMed ID: 16892075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cells for allogeneic transplantation: a review.
    Cutler C; Antin JH
    Stem Cells; 2001; 19(2):108-17. PubMed ID: 11239165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood and bone marrow hematopoietic stem cells: are they the same?
    Janssen WE
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):19-27. PubMed ID: 8211212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
    Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion.
    Beaujean F; Hartmann O; Kuentz M; Le Forestier C; Divine M; Duedari N
    Bone Marrow Transplant; 1991 Oct; 8(4):291-4. PubMed ID: 1756326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
    Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
    Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.
    Watz E; Remberger M; Ringden O; Ljungman P; Sundin M; Mattsson J; Uhlin M
    Transfusion; 2015 Oct; 55(10):2339-50. PubMed ID: 25968813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.